BOSTON SCIENTIFIC CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
BOSTON SCIENTIFIC CORPORATION (BSX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $39.00M.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$7.00M.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $42.00M.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$11.00M.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$4.00M.
- BOSTON SCIENTIFIC CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$9.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-01 | |||
| 2025-12-31 | $42.00M 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $39.00M 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | $41.00M 10-Q · filed 2026-08-03 | |||
| 2025-03-31 | $39.00M 10-Q · filed 2026-05-01 | |||
| 2024-12-31 | -$11.00M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | -$2.00M 10-Q · filed 2025-11-03 | |||
| 2024-06-30 | -$8.00M 10-Q · filed 2025-08-01 | |||
| 2024-03-31 | -$7.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$4.00M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | -$8.00M 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | -$3.00M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | -$9.00M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | -$12.00M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | -$6.00M 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$6.00M 10-K · filed 2024-02-20 | |||
| 2021-09-30 | -$5.00M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$2.00M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$3.00M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$2.00M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | -$8.00M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$9.00M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$9.00M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $10.00M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | -$2.00M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | -$8.00M 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |